Celsius (NASDAQ:CELH) Announces Quarterly Earnings Results, Beats Estimates By $0.14 EPS

Celsius (NASDAQ:CELH) announced its quarterly earnings results on Thursday. The company reported $0.42 EPS for the quarter, topping analysts’ consensus estimates of $0.28 by $0.14, Zacks reports. The business had revenue of $725.11 million for the quarter, compared to analysts’ expectations of $703.68 million. Celsius had a return on equity of 36.88% and a net margin of 7.91%.The firm’s revenue for the quarter was up 172.9% compared to the same quarter last year.

Celsius Stock Down 7.9%

Shares of CELH traded down $3.54 on Friday, reaching $41.52. The stock had a trading volume of 23,647,743 shares, compared to its average volume of 7,628,433. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 2.11. Celsius has a 12-month low of $21.10 and a 12-month high of $66.74. The firm has a market capitalization of $10.71 billion, a price-to-earnings ratio of 112.22, a price-to-earnings-growth ratio of 1.25 and a beta of 1.34. The company has a 50-day simple moving average of $58.50 and a 200-day simple moving average of $49.30.

Insiders Place Their Bets

In related news, insider Paul H. Storey sold 7,500 shares of the stock in a transaction dated Wednesday, September 3rd. The shares were sold at an average price of $60.93, for a total value of $456,975.00. Following the completion of the transaction, the insider directly owned 37,550 shares in the company, valued at $2,287,921.50. This trade represents a 16.65% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Jarrod Langhans sold 5,000 shares of the business’s stock in a transaction dated Thursday, October 16th. The stock was sold at an average price of $65.00, for a total transaction of $325,000.00. Following the sale, the chief financial officer directly owned 99,227 shares in the company, valued at $6,449,755. The trade was a 4.80% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 57,500 shares of company stock worth $3,581,975. 2.55% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Scopus Asset Management L.P. bought a new stake in Celsius in the second quarter worth $59,382,000. Ameriprise Financial Inc. boosted its stake in Celsius by 20.9% in the 2nd quarter. Ameriprise Financial Inc. now owns 2,470,088 shares of the company’s stock worth $114,587,000 after purchasing an additional 426,623 shares in the last quarter. BI Asset Management Fondsmaeglerselskab A S grew its position in Celsius by 6,299.3% during the 2nd quarter. BI Asset Management Fondsmaeglerselskab A S now owns 159,343 shares of the company’s stock valued at $7,392,000 after purchasing an additional 156,853 shares during the last quarter. First Trust Advisors LP increased its stake in Celsius by 382.2% during the 2nd quarter. First Trust Advisors LP now owns 163,622 shares of the company’s stock valued at $7,590,000 after purchasing an additional 129,690 shares in the last quarter. Finally, Royal Bank of Canada increased its stake in Celsius by 79.2% during the 1st quarter. Royal Bank of Canada now owns 257,666 shares of the company’s stock valued at $9,179,000 after purchasing an additional 113,840 shares in the last quarter. Institutional investors own 60.95% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have weighed in on the stock. Needham & Company LLC increased their price target on shares of Celsius from $60.00 to $70.00 and gave the company a “buy” rating in a research report on Friday, September 5th. Jefferies Financial Group set a $72.00 price objective on shares of Celsius and gave the company a “buy” rating in a research note on Wednesday, September 3rd. Stifel Nicolaus cut their target price on Celsius from $74.00 to $60.00 and set a “buy” rating on the stock in a research note on Friday. JPMorgan Chase & Co. lowered their price target on Celsius from $76.00 to $68.00 and set an “overweight” rating for the company in a research report on Friday. Finally, Royal Bank Of Canada reiterated an “outperform” rating on shares of Celsius in a report on Thursday. Twenty investment analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Celsius presently has a consensus rating of “Moderate Buy” and a consensus target price of $62.95.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.